The International Collaborative Exfoliation Syndrome Treatment Study (ICEST)

Principal Investigator:  Robert Ritch, M.D.

Enrollment Status:  

Objective:  To determine the efficacy of the treatment with latanoprost-pilocarpine (L-PILO) versus timolol or cosopt in eyes with Exfoliation syndrome and elevated intraocular pressure. This is a multi-center, 2 year study, with 275 patients to be enrolled.

Eligibility:  Exfoliation syndrome and elevated intraocular pressure in one or both eyes. Untreated IOP greater or equal to 22. Visual Acuity 20/30 or better. Age 50-80.

Contact Information: Vincent Hugo, M.D., (212) 477-7540, ext. 334 or (212) 979-4264